Cited by 43Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

Glycemic control and self-monitoring of blood glucose in Chinese patients with type 2 diabetes on insulin: Baseline results from the COMPASS study

Open access
Ji, L, Su, Q, Feng, B, Shan, Z, Hu, R, Xing, X, Xue, Y·2016·Diabetes Research and Clinical Practice

Abstract

Aims Self monitoring of blood glucose (SMBG) is not widely utilized in insulin-treated patients with type 2 diabetes. In this analysis, we evaluated the current state of SMBG in Chinese adults with type 2 diabetes treated with insulin. Methods The 2-phase COMPASS study involved 24 centers across 10 provinces and cities in China. In the first phase, a cross sectional survey was carried out in type 2 diabetes patients receiving insulin treatment. The inclusion criteria for the study subjects in the first phase were: type 2 diabetes, insulin treatment for ≥ 3 months, and age ≥ 18 years. Evaluation was made on the status of SMBG and insulin therapy in these patients by a questionnaire. Results A total of 2819 patients (age 58.2 ± 10.8 years; 49.6% females; BMI 24.6 ± 3.4 kg/m(2)) with insulin-treated type 2 diabetes were recruited in phase I of this study. The majority of patients (80.4%) were receiving insulin treatment for at least 6 months. At baseline, the mean HbA1c was 8.5 ± 1.9% and 54.6% of patients had an HbA1c above 8%. 50.4% of the cohort had diabetes for at least 10 years, and fewer of these patients achieved HbA1c <7.0% (53 mmol/mol). At baseline, 65.8% of patients reported that daily SMBG frequency was performed on a random basis. 59.2% of patients reported that they occasionally, rarely or never follow their physician's instructions regarding SMBG. Hypoglycemia occurred in over 50% of patients, although in 71.8% of patients this was a rare occurrence. Conclusions There is low utilization of SMBG in Chinese adults with insulin-treated type 2 diabetes, with approximately two-thirds of patients reporting irregular use of SMBG. This is in line with an overall poor level of glycemic control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2015.08.005

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. China Diabetes Society. China guideline for type 2 diabetes. Chin J Diabetes 2010;20(1):S1-6.
  2. Lu J, Ji L, Guo Xiao, Gu Wei. Glycemic and HbA1c controls of T2DM patients treated with human insulin in China. Chin J Diabetes 2013;21(9):803-6.
  3. China Diabetes Society. China Guideline for type 2 diabetes. China Diabetes Soc J 2011;3(1):13-21 [Chinese].

Cited by

Sorted by citations

Authors
Ji, L., Su, Q., Feng, B., Shan, Z., Hu, R., Xing, X., & Xue, Y.
Affiliations
  • Peking University People's Hospital (CN)
  • XinHua Hospital (CN)
  • Tongji University (CN)
  • First Hospital of China Medical University (CN)
  • Huashan Hospital (CN)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Nanfang Hospital (CN)
Corresponding author
  • Ji, L
  • Su, Q
  • Feng, B
  • Shan, Z
  • Hu, R
  • Xing, X
  • Xue, Y
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2016-02
Volume
112
Pages
82-87
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2232833523
Cited by
43
References
22
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 7 · 2017: 4 · 2016: 2
FWCI
5.37
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
self-monitoring of blood glucose, type 2 diabetes, insulin therapy, glycemic control, HbA1c, hypoglycemia, Chinese patients, COMPASS study
MeSH terms
Adult, Aged, Aged, 80 and over, Blood Glucose, China, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Prospective Studies, Surveys and Questionnaires, Blood Glucose Self-Monitoring, Prevalence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review